Annual SG&A
$352.50 M
+$16.82 M+5.01%
31 December 2023
Summary:
Tandem Diabetes Care annual selling, general & administrative expenses is currently $352.50 million, with the most recent change of +$16.82 million (+5.01%) on 31 December 2023. During the last 3 years, it has risen by +$91.00 million (+34.80%). TNDM annual SG&A is now at all-time high.TNDM Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$99.64 M
+$5.40 M+5.73%
30 September 2024
Summary:
Tandem Diabetes Care quarterly selling, general & administrative expenses is currently $99.64 million, with the most recent change of +$5.40 million (+5.73%) on 30 September 2024. Over the past year, it has increased by +$13.89 million (+16.20%). TNDM quarterly SG&A is now at all-time high.TNDM Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$4.02 B
-$126.78 M-3.26%
30 September 2024
Summary:
Tandem Diabetes Care TTM selling, general & administrative expenses is currently -$4.02 billion, with the most recent change of -$126.78 million (-3.26%) on 30 September 2024. Over the past year, it has dropped by -$4.37 billion (-1240.48%). TNDM TTM SG&A is now -3690.80% below its all-time high of $369.74 million, reached on 30 September 2024.TNDM TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNDM Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +16.2% | -1240.5% |
| 3 y3 years | +34.8% | +39.4% | -1637.3% |
| 5 y5 years | +112.7% | +118.7% | -2525.7% |
TNDM Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +34.8% | at high | +39.4% | -55.8% | at low |
| 5 y | 5 years | at high | +112.7% | at high | +118.7% | -60.8% | at low |
| alltime | all time | at high | +2109.9% | at high | +1570.6% | -3690.8% | at low |
Tandem Diabetes Care Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $99.64 M(+5.7%) | $369.74 M(+5.8%) |
| June 2024 | - | $94.24 M(+4.6%) | $349.43 M(-1.0%) |
| Mar 2024 | - | $90.11 M(+5.1%) | $352.80 M(+0.1%) |
| Dec 2023 | $352.50 M(+5.0%) | $85.75 M(+8.1%) | $352.50 M(-3.3%) |
| Sept 2023 | - | $79.33 M(-18.7%) | $364.44 M(-1.3%) |
| June 2023 | - | $97.61 M(+8.7%) | $369.22 M(+4.8%) |
| Mar 2023 | - | $89.81 M(-8.1%) | $352.22 M(+4.9%) |
| Dec 2022 | $335.68 M(+28.4%) | $97.69 M(+16.2%) | $335.68 M(+8.5%) |
| Sept 2022 | - | $84.10 M(+4.3%) | $309.49 M(+6.6%) |
| June 2022 | - | $80.61 M(+10.0%) | $290.31 M(+5.1%) |
| Mar 2022 | - | $73.27 M(+2.5%) | $276.22 M(+5.6%) |
| Dec 2021 | $261.51 M(+27.6%) | $71.50 M(+10.1%) | $261.51 M(+6.9%) |
| Sept 2021 | - | $64.92 M(-2.4%) | $244.53 M(+6.4%) |
| June 2021 | - | $66.52 M(+13.6%) | $229.83 M(+7.5%) |
| Mar 2021 | - | $58.56 M(+7.4%) | $213.75 M(+4.3%) |
| Dec 2020 | $204.90 M(+23.6%) | $54.52 M(+8.5%) | $204.90 M(+4.6%) |
| Sept 2020 | - | $50.23 M(-0.4%) | $195.95 M(+2.9%) |
| June 2020 | - | $50.44 M(+1.5%) | $190.37 M(+5.5%) |
| Mar 2020 | - | $49.72 M(+9.1%) | $180.49 M(+8.9%) |
| Dec 2019 | $165.74 M(+57.5%) | $45.56 M(+2.0%) | $165.74 M(+8.8%) |
| Sept 2019 | - | $44.65 M(+10.1%) | $152.35 M(+11.0%) |
| June 2019 | - | $40.56 M(+16.0%) | $137.21 M(+15.0%) |
| Mar 2019 | - | $34.96 M(+8.6%) | $119.27 M(+13.3%) |
| Dec 2018 | $105.23 M | $32.18 M(+9.1%) | $105.23 M(+11.5%) |
| Sept 2018 | - | $29.51 M(+30.4%) | $94.35 M(+11.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | $22.63 M(+8.2%) | $84.97 M(+0.6%) |
| Mar 2018 | - | $20.91 M(-1.8%) | $84.44 M(-2.2%) |
| Dec 2017 | $86.38 M(+4.3%) | $21.30 M(+5.8%) | $86.38 M(+2.7%) |
| Sept 2017 | - | $20.13 M(-9.0%) | $84.14 M(-0.7%) |
| June 2017 | - | $22.10 M(-3.3%) | $84.70 M(+1.2%) |
| Mar 2017 | - | $22.85 M(+19.8%) | $83.69 M(+1.0%) |
| Dec 2016 | $82.83 M(+5.4%) | $19.07 M(-7.8%) | $82.83 M(-1.8%) |
| Sept 2016 | - | $20.68 M(-1.9%) | $84.31 M(+1.9%) |
| June 2016 | - | $21.09 M(-4.1%) | $82.75 M(+1.8%) |
| Mar 2016 | - | $22.00 M(+7.1%) | $81.26 M(+3.4%) |
| Dec 2015 | $78.62 M(+4.7%) | $20.54 M(+7.4%) | $78.62 M(+0.5%) |
| Sept 2015 | - | $19.12 M(-2.4%) | $78.19 M(+0.3%) |
| June 2015 | - | $19.60 M(+1.3%) | $77.97 M(+2.0%) |
| Mar 2015 | - | $19.36 M(-3.8%) | $76.44 M(+1.7%) |
| Dec 2014 | $75.12 M(+68.7%) | $20.12 M(+6.5%) | $75.12 M(+8.4%) |
| Sept 2014 | - | $18.89 M(+4.6%) | $69.31 M(+11.0%) |
| June 2014 | - | $18.07 M(+0.1%) | $62.42 M(+12.1%) |
| Mar 2014 | - | $18.04 M(+26.1%) | $55.68 M(+25.1%) |
| Dec 2013 | $44.52 M(+96.2%) | $14.30 M(+19.1%) | $44.52 M(+23.1%) |
| Sept 2013 | - | $12.01 M(+6.0%) | $36.18 M(+18.1%) |
| June 2013 | - | $11.32 M(+64.5%) | $30.64 M(+58.6%) |
| Mar 2013 | - | $6.88 M(+15.4%) | $19.31 M(+55.4%) |
| Dec 2012 | $22.69 M(+42.3%) | $5.96 M(-7.7%) | $12.43 M(+92.3%) |
| Sept 2012 | - | $6.46 M | $6.46 M |
| Dec 2011 | $15.95 M | - | - |
FAQ
- What is Tandem Diabetes Care annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Tandem Diabetes Care?
- What is Tandem Diabetes Care quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Tandem Diabetes Care?
- What is Tandem Diabetes Care quarterly SG&A year-on-year change?
- What is Tandem Diabetes Care TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Tandem Diabetes Care?
- What is Tandem Diabetes Care TTM SG&A year-on-year change?
What is Tandem Diabetes Care annual selling, general & administrative expenses?
The current annual SG&A of TNDM is $352.50 M
What is the all time high annual SG&A for Tandem Diabetes Care?
Tandem Diabetes Care all-time high annual selling, general & administrative expenses is $352.50 M
What is Tandem Diabetes Care quarterly selling, general & administrative expenses?
The current quarterly SG&A of TNDM is $99.64 M
What is the all time high quarterly SG&A for Tandem Diabetes Care?
Tandem Diabetes Care all-time high quarterly selling, general & administrative expenses is $99.64 M
What is Tandem Diabetes Care quarterly SG&A year-on-year change?
Over the past year, TNDM quarterly selling, general & administrative expenses has changed by +$13.89 M (+16.20%)
What is Tandem Diabetes Care TTM selling, general & administrative expenses?
The current TTM SG&A of TNDM is -$4.02 B
What is the all time high TTM SG&A for Tandem Diabetes Care?
Tandem Diabetes Care all-time high TTM selling, general & administrative expenses is $369.74 M
What is Tandem Diabetes Care TTM SG&A year-on-year change?
Over the past year, TNDM TTM selling, general & administrative expenses has changed by -$4.37 B (-1240.48%)